It is currently Mon Apr 23, 2018 4:24 pm

News News of Gilenya

Site map of Gilenya » Forum : Gilenya

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.

Gilenya withdrawal may trigger the return of disease act.

Gilenya withdrawal may trigger the return of pre-treatment disease activity

It is difficult to identify patients at risk of disease reactivation. So in a recent study scientists at Cerrahpasa School of Medicine, Istanbul University in Turkey compared the demographic and clinical features of patients experiencing severe disease reactivation (SDR) after Gilenya was stopped, with those of patients who did not...Read more - http://www.ms-uk.org/gilenya-withdrawal-may-trigger-return-pre-treatment-disease-activity

Image
Read more : Gilenya withdrawal may trigger the return of disease act. | Views : 1370 | Replies : 0


Fingolimod granted FDA Breakthrough Therapy designation...

Fingolimod granted FDA Breakthrough Therapy designation for paediatric MS

Novartis today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for fingolimod for the treatment of children and adolescents 10 years of age or older with relapsing multiple sclerosis (MS)...Read more - http://www.ms-uk.org/fingolimod-granted-fda-breakthrough-therapy-designation-paediatric-ms

Image
Read more : Fingolimod granted FDA Breakthrough Therapy designation... | Views : 754 | Replies : 0


Children with MS - 82% lower relapse rate with Gilenya

Children and adolescents with MS experience an 82% lower relapse rate with Gilenya vs. interferon beta-1a #ECTRIMS

Pharmaceutical company Novartis has released the full results of a phase III Paradigms study investigating the safety and efficiency of Gilenya (fingolimod) vs. interferon beta-1a in children and adolescents aged 10-17 with MS...Read more - http://www.ms-uk.org/children-and-adolescents-ms-experience-82-lower-relapse-rate-gilenya-vs-interferon-beta-1a-ectrims

Image
Read more : Children with MS - 82% lower relapse rate with Gilenya | Views : 858 | Replies : 0


Gileyna significantly reduces relapses in children...

Phase III trial shows Gileyna significantly reduces relapses in children and adolescents with MS

A phase III Paradigms study in paediatric multiple sclerosis (MS) has met its primary end point, showing a significant reduction in the occurrence of relapses with Gileyna (also known as fingolimod) versus interferon beta-1a...Read more - http://www.ms-uk.org/phase-iii-trial-shows-gileyna-significantly-reduces-relapses-children-and-adolescents-ms
Read more : Gileyna significantly reduces relapses in children... | Views : 1114 | Replies : 1


Gilenya and MS in Netherlands

Hello Everyone,

I have recently joined this community.
I have a question regarding the access to gilenya in Netherlands.
I currently live in Turkey and in Turkey everyone has a public health insurance and most of the medicines are reimbursed. I have MS for 7 years and currently using gilenya for one year. I do not pay anything for this drug in Turkey, i go to my neurologist, she prescribes it and i get it ...
Read more : Gilenya and MS in Netherlands | Views : 1277 | Replies : 0


59.6% of Gilenya patients achieve NEDA in study

Novartis has announced the results of a phase IV multiple sclerosis (MS) clinical outcomes and MRI study in the US. It confirmed the effectiveness of Gilenya (fingolimod) in a real-world setting, supporting previous findings from phase III trials...Read more - http://www.ms-uk.org/75-gilenya-patients-achieve-neda-study-040517
Read more : 59.6% of Gilenya patients achieve NEDA in study | Views : 1559 | Replies : 0


Survey Closed

Thank you for your input! We truly appreciate your time and your feedback.
Read more : Survey Closed | Views : 1233 | Replies : 1


Coughing side effect?

Hey All,

I started on Gilenya back in November last year. It has been great, no complaints. However in the past few weeks I've picked up this cough that I cannot kick. One of the side effects of this is apparently a cough. Does anyone here have experience with this at all? Is it common? Thanks.
Read more : Coughing side effect? | Views : 1352 | Replies : 2


Could FDA approved drug be used to treat SPMS?

Could FDA approved drug be used to treat secondary progressive MS?

A drug, which has already been approved by the Food and Drug Federation has been found to supress chronic inflammation in the central nervous system in a mouse study...Read more - http://www.ms-uk.org/could-fda-approved-drug-be-used-treat-secondary-progressive-ms-100217
Read more : Could FDA approved drug be used to treat SPMS? | Views : 1164 | Replies : 0


I'm switching to gilenya and I'm scared help please

So if i was on copaxone and it didn't work, and I switched to tecfidera only to get new enhanced lesions, and my dr is suggesting gilenya is that because there's a pattern in people who reject medications that typically work better wwith gilenya? Is it worth the side effects which are a step up from my previous treatments? Please help I have to decide on the medication and I am so scared of failing ...
Read more : I'm switching to gilenya and I'm scared help please | Views : 1624 | Replies : 1


 

Login  •  Register


Statistics

Total posts 242880 • Total topics 26657 • Total members 17828


Contact us | Terms of Service